Changes in metamorphopsia after the treat-and-extend regimen of anti-VEGF therapy for macular edema associated with branch retinal vein occlusion
Fig 2
LogMAR VA and CMT changes after treatment.
LogMAR VA (a) and CMT (b) changes at 1, 6, 12, and 18 months after treatment (n = 27) are visualized by box-and-whisker plots. The thick horizontal line within each box indicates the median score, and the top and bottom of each box indicate the 75th and 25th percentiles. Whiskers above the box indicate values within 1.5× of the interquartile range (IQR) of the upper quartile, and whiskers below the box indicate values within 1.5× of the IQR of the lower quartile. Best-corrected VA (logMAR) = best-corrected visual acuity (logarithm of minimal angle of resolution); CMT = central macular thickness. * Indicates P < 0.0001 compared to baseline values.